Marshall Wace
PRVA icon

Marshall Wace’s Privia Health PRVA Stock Holding History

Marshall Wace’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-92,903
Closed -$2.14M – 3305
2025
Q2 		$2.14M Sell
92,903
-270,172
-74% -$6.26M ﹤0.01% 1526
2025
Q1 		$8.15M Buy
363,075
+24,816
+7% +$577K 0.01% 849
2024
Q4 		$6.61M Buy
338,259
+178,548
+112% +$3.54M 0.01% 945
2024
Q3 		$2.91M Buy
+159,711
New +$3.05M ﹤0.01% 1227
2022
Q4 		– Sell
-29,425
Closed -$1M – 3321
2022
Q3 		$1M Sell
29,425
-5,285
-15% -$195K ﹤0.01% 2410
2022
Q2 		$1.01M Sell
34,710
-416,871
-92% -$10.6M ﹤0.01% 2428
2022
Q1 		$12.1M Buy
451,581
+217,237
+93% +$5.13M 0.02% 755
2021
Q4 		$6.06M Buy
+234,344
New +$5.84M 0.01% 1222

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace's PRVA Position: Q3 2025 in Review

Marshall Wace sold out of Privia Health (PRVA) in Q3 2025, closing a stake of 92,903 shares — an estimated $2.14M sold.

Marshall Wace first reported a position in PRVA in Q4 2021 and held it in 8 quarters. The position peaked at $12.1M in Q1 2022. 259 funds tracked by Wall St. Rank hold PRVA as of Q3 2025.

  • Marshall Wace reported no remaining Privia Health position as of Q3 2025 after selling out during the quarter.
  • Marshall Wace sold 92,903 Privia Health shares in Q3 2025, an estimated $2.14M.
  • Marshall Wace first reported a position in Privia Health in Q4 2021 and held it in 8 quarters.
  • Marshall Wace's Privia Health position peaked at $12.1M in Q1 2022.
  • 259 funds tracked by Wall St. Rank held Privia Health as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.